FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
View on SAM.gov ↗ Sign in to save
- Type
- Contract
- Notice type
- Special Notice
- Agency
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF
- Sub-agency
- FOOD AND DRUG ADMINISTRATION
- Office
- FDA OFFICE OF ACQ GRANT SVCS
- Solicitation #
- FDABAA-27-00123
- Posted
- Nov 16, 2026
- Response due
- Jan 22, 2027
- Archive date
- Sep 30, 2027
- NAICS
- 541714
- PSC
- AJ11
- Set-aside
- No Set aside used
- Contact
- Ian Weiss · Ian.Weiss@fda.hhs.gov · 3017965728
- Source
- SAM.gov
Description
Amendment 001 - 10/30/26 - Updated the proposal due date from 2/1/27 at 5:00 pm to 1/22/27 at 5:00 pm. Updated the Special Notice Archive date from 15 days after response date to 09/30/27. Amendment 002 - 11/16/26: Summary of changes BAA Notice (FDABAA-27-00123) - Amendment 002: Page 2 – Added updated information on BAA Day. BAA Day: FY27 FDA BAA Day will provide an opportunity to learn more about the application process and the FDA’s priorities for regulatory science research. Fiscal Year (FY) 2027 FDA Broad Agency Announcement Day - 12/08/2026 | FDA Page 7 – Added updated information on BAA Day. BAA Day for FY2027 will be hosted on December 8, 2026 from 1:00 PM - 4:00 PM Eastern Standard Time, as a virtual only event and will provide an opportunity to learn more about the application process and FDA’s priorities for regulatory research (Fiscal Year (FY) 2027 FDA Broad Agency Announcement Day - 12/08/2026 | FDA). Page 14 – Added new research interest to Section - 2. Enhancing Nonclinical Development 16. Compare multiple human tooth enamel evaluation techniques (including but not limited to surface and cross-sectional microhardness) to explore critical parameters and refine demineralization-remineralization NAMs for the testing of over-the-counter anticaries dentifrice drug products. Page 52 – Updated Section - 22 - Tobacco and Nicotine with Super Intelligence (SI) (SI)[18] [18] Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI) Page 53-56 - Section - 22 - Tobacco and Nicotine Updated numerical bullet points. The content did not change. Added page numbers to the footer of the BAA Notice. Notice: In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement. FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation.